Drugs / Fluocinolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00008515 | Jan → Dec 2001 | age-related macular degeneration, choroidal neovascularization | National Eye Institute (NEI) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01743690 Background | Mar 2012 → Dec 2015 | candidiasis, lichen planus, oral | University of Copenhagen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluocinolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00008515 ↗ |
| Modality | Other / unclassified | “pellet of the steroid fluocinolone” NCT00008515 ↗ |
| Route | Intravitreal | “sustained-release fluocinolone intravitreal implant” NCT00008515 ↗ |